Tfpi

  • Official Full Name

    Tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
  • Overview

    Tissue factor pathway inhibitor (or TFPI) is a single-chain polypeptide which can reversibly inhibit Factor Xa (Xa) and Thrombin (Factor IIa). While Xa is inhibited, the Xa-TFPI complex can subsequently also inhibit the FVIIa-tissue factor complex. TFPI contributes significantly to the inhibition of Xa in vivo, despite being present at concentrations of only 2.5 Nm. This gene encodes a protease inhibitor that regulates the tissue factor (TF)-dependent pathway of blood coagulation. The coagulation process initiates with the formation of a factor VIIa-TF complex, which proteolytically activates additional proteases (factors IX and X) and ultimately leads to the formation of a fibrin clot. The product of this gene inhibits the activated factor X and VIIa-TF proteases in an autoregulatory loop. The encoded protein is glycosylated and predominantly found in the vascular endothelium and plasma in both free forms and complexed with plasma lipoproteins. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been confirmed.
  • Synonyms

    TFPI;EPI;TFI;LACI;TFPI1;tissue factor pathway inhibitor;anti-convertin;extrinsic pathway inhibitor

Recombinant Proteins

  • Human
  • Rhesus macaque
  • Mouse
  • Rat
  • Rabbit
  • HEK293
  • E.coli
  • Human Cells
  • Rabbit
  • Insect Cells
  • Baculovirus
  • Yeast
  • His
  • GST&His
  • Non
  • GST
  • DDK&Myc
  • Avi&His
  • Avi&Fc&His
Cat.# Product name Source (Host) Species Tag Protein Length Price
TFPI-875H Active Recombinant Human TFPI protein, His-tagged HEK293 Human His Asp 29 - Lys 282
TFPI-876H Recombinant Human TFPI protein, His-tagged, Biotinylated HEK293 Human His Asp 29 - Lys 282
TFPI-105H Recombinant Human TFPI protein, His-tagged E.coli Human His Asp29~Glu210
TFPI-106H Recombinant Human TFPI protein, His/GST-tagged E.coli Human GST&His Asp29~Met304
TFPI-107H Recombinant Human TFPI protein, His/GST-tagged E.coli Human GST&His Asp29~Cys251
TFPI-2333H Recombinant Human TFPI, His-tagged E.coli Human His 299aa
TFPI-4683R Recombinant Rhesus macaque TFPI protein, His-tagged HEK293 Rhesus macaque His 254
Tfpi-574M Recombinant Mouse Tfpi Protein, His-tagged E.coli Mouse His Leu29~Asn306
Tfpi-575R Recombinant Rat Tfpi Protein, His-tagged E.coli Rat His Leu29~His302
TFPI-576R Recombinant Rabbit TFPI Protein, His/GST-tagged E.coli Rabbit GST&His Lys39~Gly275
Tfpi-874M Recombinant Mouse Tfpi, His tagged Human Cells Mouse His 1-289 a.a.
Tfpi-981M Active Recombinant Mouse Tfpi protein(Met1-Lys289), His-tagged HEK293 Mouse His Met1-Lys289
TFPI-2746HCL Recombinant Human TFPI cell lysate Human Cells Human Non
TFPI-2843MCL Recombinant Mouse TFPI cell lysate Human Cells Mouse Non
CAB11612RM Rabbit Monoclonal Antibody to Mouse Tissue Factor Pathway Inhibitor Rabbit Mouse Non
CAB11613RM Rabbit Monoclonal Antibody to Mouse Tissue Factor Pathway Inhibitor Rabbit Mouse Non
TFPI-1246H Recombinant Human TFPI Protein, His-tagged HEK293 Human His Asp29-Met304
TFPI-2145H Active Recombinant Human TFPI protein, His-tagged HEK293 Human His Met1-Lys282
TFPI-2260R Recombinant Rabbit TFPI protein, His-tagged Insect Cells Rabbit His 25-300aa
TFPI-3565H Recombinant Human TFPI protein, GST-tagged E.coli Human GST 29-280aa
TFPI-3566R Recombinant Rabbit TFPI protein, His-tagged E.coli Rabbit His 25-300a
TFPI-42FLH Recombinant Human TFPI Protein, Full Length, C-His tagged Baculovirus Human His Full L. Full Length
TFPI-5070R Recombinant Rabbit TFPI protein, His-tagged HEK293 Rabbit His 25-300aa
TFPI-5528R Recombinant Rabbit TFPI protein, His-tagged Yeast Rabbit His 25-300a
TFPI-5798H Recombinant Human TFPI Protein, Myc/DDK-tagged, C13 and N15-labeled HEK293 Human DDK&Myc
Tfpi-6383M Recombinant Mouse Tfpi Protein, Myc/DDK-tagged HEK293 Mouse DDK&Myc
TFPI-6424H Recombinant Human TFPI Protein (Asp29-Phe209), N-His tagged E.coli Human His Asp29-Phe209
TFPI-646H Recombinant Human TFPI protein, His-Avi-tagged HEK293 Human Avi&His Asp29-Lys282
TFPI-646HB Recombinant Human TFPI protein, His-Avi-tagged, Biotinylated HEK293 Human Avi&His Asp29-Lys282
TFPI-707H Recombinant Human TFPI Protein, MYC/DDK-tagged HEK293 Human DDK&Myc
TFPI-751H Recombinant Human TFPI Protein, Biotinylated HEK293 Human 304
TFPI-752H Recombinant Human TFPI Protein HEK293 Human 304
TFPI-753R Recombinant Rhesus macaque TFPI Protein HEK293 Rhesus macaque 304
Tfpi-9155M Recombinant Mouse Tfpi Protein, His (Fc)-Avi-tagged HEK293 Mouse Avi&Fc&His
Tfpi-9155M-B Recombinant Mouse Tfpi Protein Pre-coupled Magnetic Beads HEK293 Mouse

    Background

    What is TFPI protein?

    TFPI gene (tissue factor pathway inhibitor) is a protein coding gene which situated on the long arm of chromosome 2 at locus 2q32. This gene encodes a Kunitz-type serine protease inhibitor that regulates the tissue factor (TF)-dependent pathway of blood coagulation. The coagulation process initiates with the formation of a factor VIIa-TF complex, which proteolytically activates additional proteases (factors IX and X) and ultimately leads to the formation of a fibrin clot. The product of this gene inhibits the activated factor X and VIIa-TF proteases in an autoregulatory loop. The TFPI protein is consisted of 304 amino acids and TFPI molecular weight is approximately 35.0 kDa.

    What is the function of TFPI protein?

    TFPI is a key natural anticoagulant protein that directly inhibits the activity of factor Xa and factor VIIa/tissue factor complexes through its Kunitz type domain, thereby controlling the initiation phase of blood coagulation. TFPI is expressed on a variety of cell surfaces and works synergistically with protein S to enhance its ability to inhibit Xa. It plays a vital role in maintaining blood flow and preventing thrombosis, and is also involved in the regulation of vascular inflammation, tumor growth and metastasis. The expression level of TFPI changes in some diseases, such as increased expression in atherosclerosis, and reduces mortality by improving symptoms in diseases such as sepsis and DIC. In addition, TFPI has anti-inflammatory effects and may be used to inhibit intimal hyperplasia and postoperative deep vein thrombosis.

    TFPI-7.jpg

    Fig1. Functions of TFPI. (George J Broze Jr, 2012)

    TFPI related signaling pathway

    TFPI is a key regulatory protein involved in the coagulation cascade, primarily functioning to inhibit the tissue factor-mediated activation of coagulation factors VIIa and Xa. This inhibition helps maintain blood fluidity by preventing excessive clot formation. TFPI achieves this through direct binding to these activated factors, effectively blocking their interaction with other components of the coagulation pathway. Additionally, TFPI plays a role in modulating inflammation and angiogenesis, demonstrating its significance beyond mere anticoagulation. Dysregulation of TFPI signaling can lead to thrombotic disorders, highlighting its importance in maintaining hemostasis.

    TFPI related diseases

    TFPI is a key natural anticoagulant protein that controls the initiation phase of blood clotting by inhibiting the activity of factor Xa and factor VIIa/tissue factor complexes. TFPI plays a role in a variety of diseases, including atherosclerosis, infectious diseases, malignancies, cardiovascular diseases, and pregnancy-related conditions such as preeclampsia and HELLP syndrome. Expression levels of TFPI may vary in these diseases, making it a potential biomarker and therapeutic target.

    Bioapplications of TFPI

    As a natural anticoagulant protein, TFPI controls the initiation phase of blood clotting by inhibiting the activity of factor Xa and factor VIIa/tissue factor complexes. It plays a role in the treatment of atherosclerosis, infectious diseases, malignancies, cardiovascular diseases, and pregnancy-related diseases, and is a potential biomarker and therapeutic target in the research and treatment of these diseases

    In addition, the application of TFPI in the treatment of hemophilia also shows potential. By inhibiting TFPI, thrombin production during clotting can be restored, thereby improving clotting function in hemophiliacs. At present, monoclonal antibody and oligonucleotide drugs targeting TFPI have been shown to improve the clotting ability of hemophilia patients in clinical trials. The advantage of these therapies is that they can be administered by subcutaneous injection, which is expected to reduce the treatment burden of patients.

    Case Study

    Case Study 1: Julie A Peterson, 2021

    ELISA and immunofluorescence tests showed that TFPIα is found in the extracellular matrix of endothelial cells, with a distinct intracellular and matrix pattern. Flow cytometry revealed TFPIβ on the cell surface, but not TFPIα. Further confirmation of TFPIα in the matrix came from ELISA and immunohistochemistry on umbilical cord veins. The C terminus of TFPIα binds to glycosaminoglycans in the matrix, and this binding can be competed by a VEGF peptide, indicating a role in modulating VEGF responses. TFPIα also interacts with specific extracellular matrix proteoglycans, as shown by immunofluorescence in the human kidney. The findings suggest that TFPIα is associated with unique proteoglycan structures rather than being present on the cell surface.

    TFPI-1.jpg

    Fig1. Flow cytometry was used to identify TFPIα and TFPIβ on the surface of suspended Ea.hy926 cells.

    TFPI-2.jpg

    Fig2. Proteins removed from Ea.hy926 conditioned media by the TFPI (tissue factor pathway inhibitor) α C terminus.

    Case Study 2: Ann Jeffers, 2015

    Tissue factor pathway inhibitor (TFPI) is a key regulator of the extrinsic coagulation pathway, and its activity can be influenced by pathophysiological factors. Researchers investigated the regulation of TFPI by thrombin in human pleural mesothelial cells (HPMCs) and found that thrombin significantly reduces TFPI expression by over 70%. This reduction enhances factor X activation. The effect of thrombin on TFPI is mediated by protease-activated receptor (PAR)-1 and involves the PI3K/Akt and NF-κB signaling pathways. This study reveals a new mechanism by which thrombin controls TFPI expression in HPMCs, potentially promoting a procoagulant response.

    TFPI-3.jpg

    Fig3. Cell surface TF activity was determined in the presence of TFPI neutralizing antibody or isotype control.

    TFPI-4.jpg

    Fig4. CM were resolved by SDS-PAGE and probed for changes in TFPI protein expression.

    Quality Guarantee

    High Purity

    SDS-PAGE (TFPI-106H).jpg

    Fig1. SDS-PAGE (TFPI-106H)

    .

    SDS-PAGE (TFPI-646HB).jpg

    Fig2. SDS-PAGE (TFPI-646HB)

    Involved Pathway

    Tfpi involved in several pathways and played different roles in them. We selected most pathways Tfpi participated on our site, such as Complement and coagulation cascades, which may be useful for your reference. Also, other proteins which involved in the same pathway with Tfpi were listed below. Creative BioMart supplied nearly all the proteins listed, you can search them on our site.

    Pathway Name Pathway Related Protein
    Complement and coagulation cascades PLAU,C4BP,MASP1,C3,F3,C5,C6,MASP2,LOC100514666,SERPINA5

    Protein Function

    Tfpi has several biochemical functions, for example, endopeptidase inhibitor activity,serine-type endopeptidase inhibitor activity. Some of the functions are cooperated with other proteins, some of the functions could acted by Tfpi itself. We selected most functions Tfpi had, and list some proteins which have the same functions with Tfpi. You can find most of the proteins on our site.

    Function Related Protein
    endopeptidase inhibitor activity UCHL5,AHSG,USP14,C3B.2,SERPINA1D,SLPI,PSMF1,RECK,Cstb,SERPINA1E
    serine-type endopeptidase inhibitor activity CD109,ITIH3,APP,FURIN,SERPINB1B,SERPINF2,WFDC3,ITIH6,SPINK7,SERPINA3

    Interacting Protein

    Tfpi has direct interactions with proteins and molecules. Those interactions were detected by several methods such as yeast two hybrid, co-IP, pull-down and so on. We selected proteins and molecules interacted with Tfpi here. Most of them are supplied by our site. Hope this information will be useful for your research of Tfpi.

    ssrna_ug

    Resources

    References

    • Luna, E; Agrawal, P; et al. Evaluation of Immunostimulatory Potential of Branded and US-Generic Enoxaparins in an In Vitro Human Immune System Model. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS 21:211-222(2015).
    • Franchini, M; et al. Next-generation treatment of acquired hemophilia A. EXPERT OPINION ON ORPHAN DRUGS 3:245-251(2015).

    Ask a Question for All Tfpi Products

    Required fields are marked with *

    My Review for All Tfpi Products

    Required fields are marked with *